| Living Community Of St Joseph | |
| 1202 Heartland Road, Saint Joseph, Missouri 64506 | |
| (816) 671-8500 | |
| Name | Living Community Of St Joseph |
|---|---|
| Location | 1202 Heartland Road, Saint Joseph, Missouri |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 96 |
| Occupancy Rate | 77.29% |
| Medicare ID (CCN) | 265784 |
| Legal Business Name | Living Community Of St. Joseph |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1093712549 |
| Organization Name | LIVING COMMUNITY OF ST. JOSEPH |
| Address | 1202 Heartland Rd, Saint Joseph, MO 64506 |
| Phone Number | 816-671-8500 |
News Archive
The REal-time Assessment of Community Transmission-2 (REACT-2) program completed its fifth round of community surveys in the days between January 26 and February 8, 2021. The findings appear in a new article in the BMJ on February 25, 2021, showing that natural infection and vaccination together account for around 14% seropositivity rates in England at present.
COVID-19 infection may cause subacute thyroiditis, according to a new case study published in The Journal of Clinical Endocrinology & Metabolism.
Science Speaks interviews John Vertefeuille, the country director for CDC in Haiti, "about his time heading the Global AIDS Program in Nigeria, efforts to extend HIV prevention messages to youth in Tanzania with cell phones, and a brief update on current immunization efforts underway in Haiti."
New research supported by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) shows that the anticonvulsant medication gabapentin, which is used for certain types of seizures, can be an effective treatment for the pain and other symptoms associated with the common, often hard-to-treat chronic pain disorder, fibromyalgia.
One of mainland China's leading pharmaceutical companies, has announced that it was granted an additional patent related to its Rh-Apo2L anti-cancer drug, the second of three patents that had been applied for which Aida believes places it at the vanguard of China's pharmaceutical industry.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The REal-time Assessment of Community Transmission-2 (REACT-2) program completed its fifth round of community surveys in the days between January 26 and February 8, 2021. The findings appear in a new article in the BMJ on February 25, 2021, showing that natural infection and vaccination together account for around 14% seropositivity rates in England at present.
COVID-19 infection may cause subacute thyroiditis, according to a new case study published in The Journal of Clinical Endocrinology & Metabolism.
Science Speaks interviews John Vertefeuille, the country director for CDC in Haiti, "about his time heading the Global AIDS Program in Nigeria, efforts to extend HIV prevention messages to youth in Tanzania with cell phones, and a brief update on current immunization efforts underway in Haiti."
New research supported by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) shows that the anticonvulsant medication gabapentin, which is used for certain types of seizures, can be an effective treatment for the pain and other symptoms associated with the common, often hard-to-treat chronic pain disorder, fibromyalgia.
One of mainland China's leading pharmaceutical companies, has announced that it was granted an additional patent related to its Rh-Apo2L anti-cancer drug, the second of three patents that had been applied for which Aida believes places it at the vanguard of China's pharmaceutical industry.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 3 |
| Total Amount of Fines in Dollars | $51470 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 29.8 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.41 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 43.42 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.47 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 10.82 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.37 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.58 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 10.9 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 90.92 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 3.17 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 34.79 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 2.61 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 14.93 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.29 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 80.49 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 85.11 | 82.93 |
News Archive
The REal-time Assessment of Community Transmission-2 (REACT-2) program completed its fifth round of community surveys in the days between January 26 and February 8, 2021. The findings appear in a new article in the BMJ on February 25, 2021, showing that natural infection and vaccination together account for around 14% seropositivity rates in England at present.
COVID-19 infection may cause subacute thyroiditis, according to a new case study published in The Journal of Clinical Endocrinology & Metabolism.
Science Speaks interviews John Vertefeuille, the country director for CDC in Haiti, "about his time heading the Global AIDS Program in Nigeria, efforts to extend HIV prevention messages to youth in Tanzania with cell phones, and a brief update on current immunization efforts underway in Haiti."
New research supported by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) shows that the anticonvulsant medication gabapentin, which is used for certain types of seizures, can be an effective treatment for the pain and other symptoms associated with the common, often hard-to-treat chronic pain disorder, fibromyalgia.
One of mainland China's leading pharmaceutical companies, has announced that it was granted an additional patent related to its Rh-Apo2L anti-cancer drug, the second of three patents that had been applied for which Aida believes places it at the vanguard of China's pharmaceutical industry.
› Verified 8 days ago
Carriage Square Living & Rehab Center Location: 4009 Gene Field Road, Saint Joseph, Missouri 64506 Phone: (816) 364-1526 | |
Abbey Woods Center For Rehabilitation And Healing Location: 5026 Faraon St, Saint Joseph, Missouri 64506 Phone: (816) 279-1591 | |
Diversicare Of St Joseph Location: 3002 North 18th St, Saint Joseph, Missouri 64505 Phone: (816) 364-4200 | |
St Joseph Senior Living Location: 1317 North 36th Street, Saint Joseph, Missouri 64506 Phone: (816) 676-1630 | |
Living Community Of St Joseph Location: 1202 Heartland Road, Saint Joseph, Missouri 64506 Phone: (816) 671-8500 | |